C-peptide: A redundant relative of insulin?

Diabetologia

Volumn 50, Issue 3, 2007, Pages 500-502

  Luzi, L ^a   Zerbini, G ^a   Caumo, A ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

C peptide; Diabetic complications; Type 1 diabetes

Indexed keywords

C PEPTIDE; COMPLEMENTARY DNA; INSULIN; INSULIN RECEPTOR;

AMINO TERMINAL SEQUENCE; BIOTINYLATION; CELL SECRETION; CHEMOLUMINESCENCE; GENE EXPRESSION; HUMAN; IMMUNOPRECIPITATION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; KINETICS; LYSOSOME; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; SHORT SURVEY;

C-PEPTIDE; DIABETES MELLITUS, TYPE 2; HUMANS; INSULIN;

EID: 33846848953     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-006-0576-x     Document Type: Short Survey

References (18)

1. Luzi L, DeFronzo RA (1989) Effect of loss of first-phase insulin secretion on hepatic glucose production and tissue glucose disposal in humans. Am J Physiol 257:E241-E246
2. Caumo A, Luzi L (2004) First-phase insulin secretion: does it exist in real life? Considerations on shape and function. Am J Physiol Endocrinol Metab 287:E371-E385
3. Ferrannini E, Cobelli C (1987) The kinetics of insulin in man, II. Role of the liver. Diabet Metab Rev 3:365-397
4. Eaton RP, Allen RC, Schade DS, Erickson KM, Standefer J (1980) Prehepatic insulin production in man: kinetic analysis using peripheral connecting peptide behavior. J Clin Endocrinol Metab 51:520-528
5. Polonsky KS, Rubenstein AH (1986) Current approaches to measurement of insulin secretion. Diabet Metab Rev 2:315-329
6. Wahren J, Ekberg K, Jörnvall H (2007) C-peptide is a bioactive peptide. Diabetologia DOI 10.1007/s00125-006-0559-y
7. Al-Rasheed NM, Willars GB, Brunskill NJ (2006) C-peptide signals via Gai to protect against TNF-α-mediated apoptosis of opossum kidney proximal tubular cells. J Am Soc Nephrol 17:986-995
8. Rigler R, Pramanik A, Jonasson P et al (1999) Specific binding of proinsulin C-peptide to human cell membranes. Proc Natl Acad Sci USA 96:13318-13323
9. Maestroni A, Ruggieri D, Dell'Antonio G, Luzi L, Zerbini G (2005) C-peptide increases the expression of vasopressin-activated calcium-mobilizing receptor gene through a G protein-dependent pathway. Eur J Endocrinol 152:135-141
10. Grunberger G, Qiang X, Li Z et al (2001) Molecular basis for the insulinomimetic effects of C-peptide. Diabetologia 44:1247-1257
11. Luzi L (1998) Pancreas transplantation and diabetic complications. N Engl J Med 339:115-117
12. Fiorina P, Folli F, Zerbini G et al (2003) Islet transplantation is associated with improvement of renal function among uremic patients with type I diabetes mellitus and kidney transplants. J Am Soc Nephrol 14:2150-2158
13. Shapiro AM (2003) Islet transplants and impact on secondary diabetic complications: does C-peptide protect the kidney? J Am Soc Nephrol 14:2214-2216
14. Johansson BL, Borg K, Fernqvist-Forbes E, Kernell A, Odergren T, Wahren J (2000) Beneficial effects of C-peptide on incipient nephropathy and neuropathy in patients with type 1 diabetes mellitus. Diabet Med 17:181-189
15. Bezemer ID, Rinaldi S, Dossus L et al (2005) C-peptide, IGF-I, sex-steroid hormones and adiposity: a cross-sectional study in healthy women within the European Prospective Investigation into Cancer and Nutrition (EPIC). Cancer Causes Control 16:561-572
16. Falk RT, Brinton LA, Madigan MP et al (2006) Interrelationships between serum leptin, IGF-1, IGFBP3, C-peptide and prolactin and breast cancer risk in young women. Breast Cancer Res Treat 98:157-165
17. Verheus M, Peeters PH, Rinaldi S et al (2006) Serum C-peptide levels and breast cancer risk: results from the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer 119:659-667
18. Wei EK, Ma J, Pollak MN et al (2006) C-peptide, insulin-like growth factor binding protein-1, glycosylated hemoglobin, and the risk of distal colorectal adenoma in women. Cancer Epidemiol Biomark Prev 15:750-755